Félix G. R.
- Country
- Spain
- Department
- Servicio Enfermedades Infecciosas
Research Overview
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in HIV-1 Infected Treatment-Naïve Participants
- A Phase 3 Open-label Clinical Study of Doravirine/Islatravir (DOR/ISL [100 mg/0.25 mg]) Once Daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL (100 mg/0.75 mg) QD in a Phase 3 Clinical Study
Data & Insights
Has run more than one trial at 35 of 64 partner sites.
Specializations
HIV Treatment Research
This clinical investigator specializes in the evaluation of novel antiretroviral therapies for treating HIV-1 infection, with particular focus on combination treatments involving innovative drug formulations.
- Treatment-naïve patient therapies
- Antiretroviral switching strategies
- Long-term therapeutic efficacy
The investigator assesses therapeutic responses through viral load monitoring and safety evaluations.
Therapeutic Innovation
Research activities center on evaluating emerging antiretroviral combinations, particularly investigating the clinical potential of doravirine-based therapies in various treatment scenarios.
- Novel drug combinations
- Treatment optimization
- Therapeutic alternatives
The investigator focuses on developing effective treatment options for different patient populations.
Clinical Safety Assessment
The investigator conducts comprehensive evaluations of treatment safety profiles and therapeutic tolerability in HIV-1 patients across different treatment durations.
- Long-term safety monitoring
- Treatment tolerability assessment
- Patient response evaluation
Research includes extended safety observations up to 96 weeks of treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.